Hong B - Search Results

1

Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents.

Wang W, Gallant JN, Katz SI, Dolloff NG, Smith CD, Abdulghani J, Allen JE, Dicker DT, Hong B, Navaraj A, El-Deiry WS. Wang W, et al. Among authors: hong b. Cancer Biol Ther. 2011 Aug 1;12(3):229-38. doi: 10.4161/cbt.12.3.17033. Epub 2011 Aug 1. Cancer Biol Ther. 2011. PMID: 21725212

2

Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: evidence for the role of c-Jun N-terminal kinase activation.

Cheng H, Hong B, Zhou L, Allen JE, Tai G, Humphreys R, Dicker DT, Liu YY, El-Deiry WS. Cheng H, et al. Among authors: hong b. Cell Cycle. 2012 Sep 1;11(17):3312-23. doi: 10.4161/cc.21670. Epub 2012 Aug 16. Cell Cycle. 2012. PMID: 22895172 Free PMC article.

3

Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.

Zhang S, Zhou L, Hong B, van den Heuvel AP, Prabhu VV, Warfel NA, Kline CL, Dicker DT, Kopelovich L, El-Deiry WS. Zhang S, et al. Among authors: hong b. Cancer Res. 2015 Sep 15;75(18):3842-52. doi: 10.1158/0008-5472.CAN-13-1079. Epub 2015 Aug 20. Cancer Res. 2015. PMID: 26294215 Free PMC article.

4

Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation.

Prabhu VV, Hong B, Allen JE, Zhang S, Lulla AR, Dicker DT, El-Deiry WS. Prabhu VV, et al. Among authors: hong b. Cancer Res. 2016 Apr 1;76(7):1989-99. doi: 10.1158/0008-5472.CAN-14-2430. Epub 2016 Jan 12. Cancer Res. 2016. PMID: 26759239

5

Therapeutic targeting of the p53 pathway in cancer stem cells.

Prabhu VV, Allen JE, Hong B, Zhang S, Cheng H, El-Deiry WS. Prabhu VV, et al. Among authors: hong b. Expert Opin Ther Targets. 2012 Dec;16(12):1161-74. doi: 10.1517/14728222.2012.726985. Epub 2012 Sep 24. Expert Opin Ther Targets. 2012. PMID: 22998602 Free PMC article. Review.

6

Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53.

Hong B, Prabhu VV, Zhang S, van den Heuvel AP, Dicker DT, Kopelovich L, El-Deiry WS. Hong B, et al. Cancer Res. 2014 Feb 15;74(4):1153-65. doi: 10.1158/0008-5472.CAN-13-0955. Epub 2013 Nov 18. Cancer Res. 2014. PMID: 24247721 Free PMC article.

7

Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities.

Hong B, van den Heuvel AP, Prabhu VV, Zhang S, El-Deiry WS. Hong B, et al. Curr Drug Targets. 2014 Jan;15(1):80-9. doi: 10.2174/1389450114666140106101412. Curr Drug Targets. 2014. PMID: 24387333 Review.

8

Tetrabutylammonium decatungstate (TBADT), a compelling and trailblazing catalyst for visible-light-induced organic photocatalysis.

Hong BC, Indurmuddam RR. Hong BC, et al. Org Biomol Chem. 2024 Apr 23. doi: 10.1039/d4ob00171k. Online ahead of print. Org Biomol Chem. 2024. PMID: 38651982 Review.

9

Retraction of "Universal theranostic CRISPR/Cas13a RNA-editing system for glioma".

Wu Y, Wang Y, Zhou J, Wang J, Zhan Q, Wang Q, Yang E, Jin W, Tong F, Zhao J, Hong B, Liu J, Kang C. Wu Y, et al. Among authors: hong b. Theranostics. 2024 Apr 6;14(6):2489. doi: 10.7150/thno.96658. eCollection 2024. Theranostics. 2024. PMID: 38646655 Free PMC article.

10

Comparative effectiveness and safety of ticagrelor and clopidogrel in patients with or without chronic liver disease: a nationwide cohort study.

Hong B, Bea S, You SC, Chang Y, Kim W, Shin JY. Hong B, et al. Am J Med. 2024 Apr 18:S0002-9343(24)00220-1. doi: 10.1016/j.amjmed.2024.03.042. Online ahead of print. Am J Med. 2024. PMID: 38641192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,903 results

Search Page